Literature DB >> 23690594

GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin.

Rebecca C Meyer1, Michelle M Giddens, Stacy A Schaefer, Randy A Hall.   

Abstract

GPR37 (also known as Pael-R) and GPR37L1 are orphan G protein-coupled receptors that are almost exclusively expressed in the nervous system. We screened these receptors for potential activation by various orphan neuropeptides, and these screens yielded a single positive hit: prosaptide, which promoted the endocytosis of GPR37 and GPR37L1, bound to both receptors and activated signaling in a GPR37- and GPR37L1-dependent manner. Prosaptide stimulation of cells transfected with GPR37 or GPR37L1 induced the phosphorylation of ERK in a pertussis toxin-sensitive manner, stimulated (35)S-GTPγS binding, and promoted the inhibition of forskolin-stimulated cAMP production. Because prosaptide is the active fragment of the secreted neuroprotective and glioprotective factor prosaposin (also known as sulfated glycoprotein-1), we purified full-length prosaposin and found that it also stimulated GPR37 and GPR37L1 signaling. Moreover, both prosaptide and prosaposin were found to protect primary astrocytes against oxidative stress, with these protective effects being attenuated by siRNA-mediated knockdown of endogenous astrocytic GPR37 or GPR37L1. These data reveal that GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin.

Entities:  

Keywords:  GPCR; MAPK; deorphanization; neurodegeneration; peptide

Mesh:

Substances:

Year:  2013        PMID: 23690594      PMCID: PMC3677493          DOI: 10.1073/pnas.1219004110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  76 in total

1.  Prosaptide D5 reverses hyperalgesia: inhibition of calcium channels through a pertussis toxin-sensitive G-protein mechanism in the rat.

Authors:  L Yan; D A Otero; M Hiraiwa; J S O'Brien
Journal:  Neurosci Lett       Date:  2000-01-07       Impact factor: 3.046

2.  Induction of macroautophagy by overexpression of the Parkinson's disease-associated GPR37 receptor.

Authors:  Daniela Marazziti; Chiara Di Pietro; Elisabetta Golini; Silvia Mandillo; Rafaele Matteoni; Glauco P Tocchini-Valentini
Journal:  FASEB J       Date:  2009-02-13       Impact factor: 5.191

3.  Pael-R transgenic mice crossed with parkin deficient mice displayed progressive and selective catecholaminergic neuronal loss.

Authors:  Hua-Qin Wang; Yuzuru Imai; Haruhisa Inoue; Ayane Kataoka; Sachiko Iita; Nobuyuki Nukina; Ryosuke Takahashi
Journal:  J Neurochem       Date:  2008-08-07       Impact factor: 5.372

Review 4.  Structural diversity of G protein-coupled receptors and significance for drug discovery.

Authors:  Malin C Lagerström; Helgi B Schiöth
Journal:  Nat Rev Drug Discov       Date:  2008-04       Impact factor: 84.694

5.  Molecular mechanism for neuro-protective effect of prosaposin against oxidative stress: its regulation of dimeric transcription factor formation.

Authors:  Takashi Ochiai; Yuka Takenaka; Yukako Kuramoto; Masakazu Kasuya; Kanemasa Fukuda; Masahiko Kimura; Hiroshi Shimeno; Roberta Misasi; Masao Hiraiwa; Shinji Soeda
Journal:  Biochim Biophys Acta       Date:  2008-07-28

6.  Expression patterns in alternative splicing forms of prosaposin mRNA in the rat facial nerve nucleus after facial nerve transection.

Authors:  Jie Chen; Shouichiro Saito; Naoto Kobayashi; Kohji Sato; Takehiro Terashita; Tetsuya Shimokawa; Katsumi Mominoki; Kyojy Miyawaki; Akira Sano; Seiji Matsuda
Journal:  Neurosci Res       Date:  2007-10-02       Impact factor: 3.304

7.  Impaired prosaposin secretion during nerve regeneration in diabetic rats and protection of nerve regeneration by a prosaposin-derived peptide.

Authors:  Corinne G Jolivalt; Yvonne Vu; Leah M Mizisin; Andrew P Mizisin; Nigel A Calcutt
Journal:  J Neuropathol Exp Neurol       Date:  2008-07       Impact factor: 3.685

8.  Pael receptor is involved in dopamine metabolism in the nigrostriatal system.

Authors:  Yuzuru Imai; Haruhisa Inoue; Ayane Kataoka; Wang Hua-Qin; Masao Masuda; Toshio Ikeda; Kayoko Tsukita; Mariko Soda; Tohru Kodama; Tatsu Fuwa; Yoshiko Honda; Satoshi Kaneko; Sadayuki Matsumoto; Kazumasa Wakamatsu; Shosuke Ito; Masami Miura; Toshihiko Aosaki; Shigeyoshi Itohara; Ryosuke Takahashi
Journal:  Neurosci Res       Date:  2007-08-15       Impact factor: 3.304

9.  A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function.

Authors:  John D Cahoy; Ben Emery; Amit Kaushal; Lynette C Foo; Jennifer L Zamanian; Karen S Christopherson; Yi Xing; Jane L Lubischer; Paul A Krieg; Sergey A Krupenko; Wesley J Thompson; Ben A Barres
Journal:  J Neurosci       Date:  2008-01-02       Impact factor: 6.167

10.  GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs.

Authors:  Daniela Marazziti; Silvia Mandillo; Chiara Di Pietro; Elisabetta Golini; Rafaele Matteoni; Glauco P Tocchini-Valentini
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-22       Impact factor: 11.205

View more
  76 in total

Review 1.  Extra sensory perception: the role of Gpr receptors in the kidney.

Authors:  Jennifer L Pluznick
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-09       Impact factor: 2.894

2.  G protein-coupled receptor 37L1 regulates renal sodium transport and blood pressure.

Authors:  Xiaoxu Zheng; Laureano D Asico; Xiaobo Ma; Prasad R Konkalmatt
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-19

Review 3.  Promoter DNA hypermethylation - Implications for Alzheimer's disease.

Authors:  Yiyuan Liu; Minghui Wang; Edoardo M Marcora; Bin Zhang; Alison M Goate
Journal:  Neurosci Lett       Date:  2019-07-24       Impact factor: 3.046

4.  GPR37L1 modulates seizure susceptibility: Evidence from mouse studies and analyses of a human GPR37L1 variant.

Authors:  Michelle M Giddens; Jennifer C Wong; Jason P Schroeder; Emily G Farrow; Brilee M Smith; Sharon Owino; Sarah E Soden; Rebecca C Meyer; Carol Saunders; J B LePichon; David Weinshenker; Andrew Escayg; Randy A Hall
Journal:  Neurobiol Dis       Date:  2017-07-06       Impact factor: 5.996

5.  Parkinson's disease-associated receptor GPR37 is an ER chaperone for LRP6.

Authors:  Birgit S Berger; Sergio P Acebron; Jessica Herbst; Stefan Koch; Christof Niehrs
Journal:  EMBO Rep       Date:  2017-03-24       Impact factor: 8.807

6.  Mice lacking Gpr37 exhibit decreased expression of the myelin-associated glycoprotein MAG and increased susceptibility to demyelination.

Authors:  Brilee M Smith; Michelle M Giddens; Jessica Neil; Sharon Owino; TrangKimberly T Nguyen; Duc Duong; Fengqiao Li; Randy A Hall
Journal:  Neuroscience       Date:  2017-06-20       Impact factor: 3.590

7.  Brain Membrane Fractionation: An Ex Vivo Approach to Assess Subsynaptic Protein Localization.

Authors:  Xavier Morató; Marc López-Cano; Paula M Canas; Rodrigo A Cunha; Francisco Ciruela
Journal:  J Vis Exp       Date:  2017-05-12       Impact factor: 1.355

Review 8.  Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker.

Authors:  Zhihui Yang; Kevin K W Wang
Journal:  Trends Neurosci       Date:  2015-05-11       Impact factor: 13.837

Review 9.  Orphan neuropeptides and receptors: Novel therapeutic targets.

Authors:  Lloyd D Fricker; Lakshmi A Devi
Journal:  Pharmacol Ther       Date:  2017-11-22       Impact factor: 12.310

10.  Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells.

Authors:  Maja S Engelstoft; Won-Mee Park; Ichiro Sakata; Line V Kristensen; Anna Sofie Husted; Sherri Osborne-Lawrence; Paul K Piper; Angela K Walker; Maria H Pedersen; Mark K Nøhr; Jie Pan; Christopher J Sinz; Paul E Carrington; Taro E Akiyama; Robert M Jones; Cong Tang; Kashan Ahmed; Stefan Offermanns; Kristoffer L Egerod; Jeffrey M Zigman; Thue W Schwartz
Journal:  Mol Metab       Date:  2013-09-04       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.